Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
Allotment of 21 47 665 Convertible warrants in to Equity shares on preferential basis pursuant to Regulation 30 read with Schedule III of SEBI LODR R...more...
As of June 2026 10.46% is owned by Indian Promoters and 89.54% by Public. Top five Promoters holding highest number of shares of Venmax Drug...more...
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.more...
Statement of Deviation & variation for the Quarter and Year ended March 31 2026.more...
The company reported standalone net profit of Rs 0.11 crore for the quarter ended March 31 2026 as compared to Rs 0.78 crore in the same period last ...more...
Audited Financial Results for the Quarter and Year ended March 31 2026more...
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 in...more...
As of March 2026 13.80% is owned by Indian Promoters and 86.20% by Public. Top five Promoters holding highest number of shares of Venmax Drugs&Pharma...more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Venmax D...more...
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026.more...
Disclosure under Regulation 31 (4) of SEBI (SAST) Regulations 2011more...
The Board has considered and approved the appointment of Mrs. Padmaja Kalyani Sadhanala as an Additional director Non Executive and Non Independent D...more...
Approval of Modification of draft Scheme of Amalgamation submitted on November 12 2025 between Hatri Pharma Private Limited (Transferor Comp...more...
Allotment of 28 00 000 Convertible warrants in to Equity shares on preferential basis and pursuant to Regulation 30 read with Schedule III of SEBI LO...more...
The company reported standalone net profit during the quarter stood at Rs 0.03 crore compared to net loss of Rs 0.50 crore in the previous y...more...
Statement of Deviation and Variation for the quarter ended December 31 2025.more...
Unaudited Financial Results for the Quarter and Nine Months ended December 31 2025.more...
Outcome of the Board Meeting held on Saturday February 7 2026 i.e today to consider and approve the Unaudited Financial Results For The Quarter And N...more...
Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 in...more...
BOARD MEETINGS Company Name : Albert David Date : 06-08-2026
Latest Videos